Kai Wang

机构：University of Washington, American Pharmacists Association · ORCID：0000-0002-1373-579X

发表论文 58 篇 · 总被引 808 次 · h-index 17

代表论文

• Engineered Cell Membrane‐Derived Nanoparticles in Immune Modulation (2021 · Advanced Science · 被引 75)
• Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy (2021 · ACS Applied Materials & Interfaces · 被引 43)
• Fe3O4-rhodamine 6G nanoparticles: An iron enhanced pH sensitive multimodal probe for fluorescence and magnetic resonance imaging of tumor cell (2023 · Journal of Material Science and Technology · 被引 20)
• Antisense oligonucleotides-Laden UiO-66@Au nanohybrid for enhanced radiotherapy against hypoxic tumor by dual-inhibition of carbonic anhydrase IX (2021 · Applied Materials Today · 被引 19)
• Regulation of pathological BBB restoration via nanostructured ROS-responsive glycolipid-like copolymer entrapping siVEGF for glioblastoma targeted therapeutics (2021 · Nano Research · 被引 18)
• Atomized Neutrophil Membrane-coated MOF Nanoparticles for Direct Delivery of Dexamethasone for Severe Pneumonia (2025 · Frontiers in Bioscience-Landmark · 被引 8)